Noreen Scherer
Chief Tech/Sci/R&D Officer presso LARIMAR THERAPEUTICS, INC.
Posizioni attive di Noreen Scherer
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| LARIMAR THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/05/2018 | - |
| Alcobra, Inc. | Chief Operating Officer | - | - |
Storia della carriera di Noreen Scherer
Precedenti posizioni note di Noreen Scherer
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Chondrial Therapeutics, Inc.
 Chondrial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Chondrial Therapeutics, Inc. operates as a biotechnology company which focuses on the treatment of rare mitochondrial diseases. Its compound is CTI-1601, which the company is developing as a potential treatment for Friedreich’s Ataxia. The company was founded by Steven R. Plump and Mark R. Payne and is headquartered in Bala Cynwyd, PA. | Chief Tech/Sci/R&D Officer | - | - |
Formazione di Noreen Scherer
| LaSalle University | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
Posizioni
| Chief Tech/Sci/R&D Officer | 2 |
| Undergraduate Degree | 1 |
| Chief Operating Officer | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| LARIMAR THERAPEUTICS, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Chondrial Therapeutics, Inc.
Chondrial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Chondrial Therapeutics, Inc. operates as a biotechnology company which focuses on the treatment of rare mitochondrial diseases. Its compound is CTI-1601, which the company is developing as a potential treatment for Friedreich’s Ataxia. The company was founded by Steven R. Plump and Mark R. Payne and is headquartered in Bala Cynwyd, PA. | Health Technology |
| Alcobra, Inc. |
- Borsa valori
- Insiders
- Noreen Scherer
- Esperienza
